Navigation Links
GenWay Biotech Appoints New Vice President Custom Laboratory Services
Date:5/8/2013

SAN DIEGO, May 8, 2013 /PRNewswire-iReach/ -- GenWay Biotech today announced the appointment of Michael Dale as the Company's new Vice President of Custom Laboratory Services. In this role, Mr. Dale will be responsible for providing leadership for GenWay Biotech Custom Services operations and business development initiatives.

"As a key member of the GenWay Biotech senior management team, Mr. Dale brings a wealth of experience and talent to his new role," commented Thomas Silberg , President and CEO of GenWay Biotech. "We look forward to Mr. Dale's leadership and insights to further improve our processes and programs as we endeavor to always provide the utmost quality for our customers."

Mr. Dale brings over thirty years of experience in the biotech industry with a reputation as a resourceful, hands-on leader with proven ability to identify and realize potential in markets, organizations, and people. His experience and knowledge working with limited resources and managing lean operations has enabled the success of several biotech and biomedical start-ups and small to mid-size organizations. Mr. Dale has held executive positions at organizations such as HTI Bio-Products, HTI Bio-Services, Vet-Stem, and Strategic BioSolutions. He holds a Bachelor degree in Business Administration from the Christian Heritage College.

"I am excited to leverage my previous years of experience in custom antibody and contract laboratory at Genway Biotech," stated Michael Dale . "For over 25 years, Genway Biotech has gained an outstanding reputation for providing quality products and services to thousands of diagnostic, pharmaceutical and academia customers. I am privileged to be part of this experienced team, and have the opportunity to help further develop the capabilities, processes and rising stature of the Company.

About GenWay Biotech, Inc.

Since 1998, GenWay Biotech has provided the diagnostic and research communities with thousands of specialty reagents and assays with unmatched quality workmanship at competitive prices. The company is recognized as a trusted out-sourcing partner throughout the world. The Company is comprised of three divisions including the catalog products and custom services divisions focused on protein and antibody solutions, and the FirstMark division focused on the development and commercialization of non-invasive diagnostic and health monitoring tests for unmet clinical needs. GenWay's headquarters are located in the heart of San Diego's biotech community in the Sorrento Valley/Mesa area. For additional information, please visit GenWayBio.com.


Media Contact:

Robert Gans GenWay Biotech, 858-458-0866, rgans@genwaybio.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE GenWay Biotech
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GenWay Biotech Appoints New Vice President of Custom/OEM
2. Plandai Biotechnology, Inc. Announces Formation Of New Entity To Develop Pharmaceutical Applications
3. Increased Dosage of Needle-Free Erectile Dysfunction Medication TriMix-gel Now Available through KRS Global Biotechnology
4. Frost & Sullivan: Pharma and Biotech Industries Headed Toward an Era of Reduced Profit Margins
5. XBiotech to Present at UBS Global Healthcare Conference
6. TriMix Laboratories Announces New TriMix-gel Partnership with KRS Global Biotechnology
7. Immune Pharmaceuticals CEO to Chair BIO International Panel "Can Israel Become the Next Biotech Startup Nation?"
8. Biotech industry has "implementation gap" around demonstrating the value of products under development
9. George Rosenkranz to Receive 2013 Biotechnology Heritage Award
10. Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
11. Prodigy Diabetes Care and OK Biotech Align Ownership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017  Eli Lilly and Company (NYSE: ... $850 million in its U.S. operations in 2017. ... enterprise, including research laboratories, manufacturing sites, and general ... by demand for Lilly products, as well as ... targeting cancer, pain, diabetes and other unmet medical ...
(Date:3/24/2017)... -- The Board of Directors of Nordic Nanovector ... including the complete 2016 Annual Accounts with notes. The report ... website in the section Investor Relations/Reports and presentations/Annual Reports. ... For further ... Financial Officer Cell: +47-91-51-95-76 Email: ir@nordicnanovector.com ...
(Date:3/23/2017)... HICKORY, N.C. , March 23, 2017  Transportation ... accolades as an end-to-end supply chain management firm with ... of Consumer Product Solutions Rick Zaffarano was ... Star of the Supply Chain by the only publication ... the global food supply chain. "Rick has ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... Vighter established ... same time by providing Prehospital Trauma Life Support (PHTLS) course scholarships to four ... prehospital trauma education developed in cooperation with the American College of Surgeons to ...
(Date:3/24/2017)... ... March 24, 2017 , ... Digital Scientists, a software ... announce the opening of a Greenville, South Carolina location. The lab has ... in Greenville. , “We’ve been working with South Carolina clients for years from our ...
(Date:3/24/2017)... ... ... Texas Physical Therapy Specialists (TexPTS) is pleased to announce the opening ... is the group’s 7th location in San Antonio and 23rd in Texas. Dr. ... from the clinic, which opened March 22, 2017. , The team of ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, proudly presents her ... 9--24, 2017. This sacred and spiritual journey during the Summer Solstice will ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... announce that they are now offering treatments for sleep apnea and TMJ at ... offices. Sleep apnea , specifically the obstructive type, is increasingly being treated ...
Breaking Medicine News(10 mins):